As human papillomavirus (HPV) vaccines become available in less developed countries, understanding women’s attitudes towards HPV vaccines can help guide approaches to immunization programs. We assessed knowledge and interest in prophylactic HPV vaccines among Kenyan women seeking women’s health services (N=147). They knew little about cervical cancer or HPV vaccine. Most women (95%, 95% confidence interval [CI]: 92%, 99%), however, were willing to have their daughters vaccinated with a vaccine that would prevent cervical cancer, with preference for an inexpensive vaccine requiring fewer doses
ObjectivesOur study aimed to assess adult women’s knowledge of human papillomavirus (HPV) and cervic...
ObjectivesOur study aimed to assess adult women’s knowledge of human papillomavirus (HPV) and cervic...
The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight again...
As human papillomavirus (HPV) vaccines become available in less developed countries, understanding w...
BackgroundCervical cancer claims the lives of 275,000 women each year; most of these deaths occur in...
Background: Human Papillomavirus associated cervical cancer in Kenya caused 3,286 deaths where cervi...
The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight again...
Background: All women are potentially at risk of developing cervical cancer at some point in their l...
Background: All women are potentially at risk of developing cervical cancer at some point in their l...
AbstractBackgroundAs human papillomavirus (HPV) vaccines become available in developing countries, a...
Sub-Saharan Africa bears the greatest burden of cervical cancer. Human papillomavirus (HPV) vaccinat...
Background: All women are potentially at risk of developing cervical cancer at some point in their l...
Sub-Saharan Africa bears the greatest burden of cervical cancer. Human papillomavirus (HPV) vaccinat...
Background: Cervical cancer strikes hard in low-resource regions yet primary prevention is still rar...
Background: Cervical cancer strikes hard in low-resource regions yet primary prevention is still rar...
ObjectivesOur study aimed to assess adult women’s knowledge of human papillomavirus (HPV) and cervic...
ObjectivesOur study aimed to assess adult women’s knowledge of human papillomavirus (HPV) and cervic...
The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight again...
As human papillomavirus (HPV) vaccines become available in less developed countries, understanding w...
BackgroundCervical cancer claims the lives of 275,000 women each year; most of these deaths occur in...
Background: Human Papillomavirus associated cervical cancer in Kenya caused 3,286 deaths where cervi...
The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight again...
Background: All women are potentially at risk of developing cervical cancer at some point in their l...
Background: All women are potentially at risk of developing cervical cancer at some point in their l...
AbstractBackgroundAs human papillomavirus (HPV) vaccines become available in developing countries, a...
Sub-Saharan Africa bears the greatest burden of cervical cancer. Human papillomavirus (HPV) vaccinat...
Background: All women are potentially at risk of developing cervical cancer at some point in their l...
Sub-Saharan Africa bears the greatest burden of cervical cancer. Human papillomavirus (HPV) vaccinat...
Background: Cervical cancer strikes hard in low-resource regions yet primary prevention is still rar...
Background: Cervical cancer strikes hard in low-resource regions yet primary prevention is still rar...
ObjectivesOur study aimed to assess adult women’s knowledge of human papillomavirus (HPV) and cervic...
ObjectivesOur study aimed to assess adult women’s knowledge of human papillomavirus (HPV) and cervic...
The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight again...